Edition:
United Kingdom

ASKA Pharmaceutical Co Ltd (4514.T)

4514.T on Tokyo Stock Exchange

1,155JPY
6:00am GMT
Change (% chg)

¥-24 (-2.04%)
Prev Close
¥1,179
Open
¥1,174
Day's High
¥1,181
Day's Low
¥1,151
Volume
75,700
Avg. Vol
132,691
52-wk High
¥2,230
52-wk Low
¥1,090

Latest Key Developments (Source: Significant Developments)

ASKA Pharmaceutical says voluntary recall of hypertension treatment drug valsartan
Friday, 6 Jul 2018 

July 6 (Reuters) - ASKA Pharmaceutical Co Ltd <4514.T>:Says it voluntarily recalls hypertension treatment drug valsartan 20mg・40mg・80mg・160mgAA from July 5 .  Full Article

Takeda Pharmaceutical and ASKA Pharmaceutical enter into licensing agreement for relugolix in women's health indications
Thursday, 31 May 2018 

May 31 (Reuters) - Takeda Pharmaceutical Co Ltd <4502.T>:Says it and ASKA Pharmaceutical Co Ltd <<<4514.T>>> announced today that they entered inter a licensing agreement to grant ASKA exclusive commercialization right for uterine fibroids and exclusive development and commercialization rights for endometriosis for Japan to maximize the product value of Takeda-owned relugolix.Based on this agreement, Takeda will receive upfront payment for granting the exclusive commercialization right for uterine fibroids and the exclusive development and commercialization rights for endometriosis in Japan as well as holding the right to receive royalties on sales.  Full Article

ASKA Pharmaceutical to set up pharmaceutical JV in India
Monday, 16 Apr 2018 

April 16 (Reuters) - ASKA Pharmaceutical Co Ltd <4514.T>:Says it will set up a pharmaceutical JV with Omnicare Drugs India Private Limited, in India, in May .Says the JV will be capitalized at $12.5 million .Says it will hold 30 percent stake in the JV .  Full Article